An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 21689 participants.

Also called NCT04524624

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 21,689 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04524624
Other papers using this trial's data
  • Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trial BMJ (Clinical research ed.), 2026-03-20 DOI, PubMed 41862204, PMC13003563 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04524624. Randomized; single masking; primary purpose prevention. Start 2020-09-01 (anticipated); primary completion 2022-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II)
Condition
Stroke
Intervention (Device)
AI-based CDSS
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct04524624
Content hash
d5ff63fe359dc60aeab41de863e58f23b2bc44c189e3fe15a56fcb5719674546